Related by context. Frequent words. (Click for all words.) 69 Aerosurf 67 MKC# 66 liposomal formulation 65 Factor VIIa 64 2 methoxyestradiol 64 Panzem R 63 Initiates Phase II 63 proteasome inhibitor 62 peripherally acting 62 AzaSite Plus 62 VEGFR2 inhibitor 62 Xanafide 62 MAP# 61 Panzem R NCD 61 TELINTRA 61 Meets Primary Endpoint 60 RH1 60 Drug Candidate 60 PEG SN# 60 ATL# [001] 60 Entereg R 60 personalized immunotherapy 60 vascular disrupting agent 60 Pivotal Phase III 60 PRT# 60 GlycoPEG GCSF 60 Phase IIb clinical trials 59 Aurexis 59 Daclizumab 59 JAK inhibitor 59 Initiate Phase 59 Guanilib 59 Receives Orphan Drug Designation 59 elotuzumab 59 TLR9 agonist 59 refractory chronic lymphocytic 59 HuMax EGFr 59 Plicera 59 preclinical efficacy 59 Inhalation Aerosol 59 phase IIa clinical 59 CCX# 58 R sorafenib tablets 58 Zoraxel 58 NeuVax 58 huC# DM4 58 HGS ETR2 58 Pimavanserin 58 orBec 58 systemically administered 58 squalamine 57 Telintra 57 BrachySil 57 Phase 2b clinical trials 57 iroxanadine 57 PSMA ADC 57 Mipomersen 57 Darinaparsin 57 iSONEP 57 gets USFDA nod 57 phase IIb clinical 57 histone deacetylase HDAC inhibitor 57 bevasiranib 57 ICA # 57 GHRH 57 Trofex 57 FDA Accepts 57 Recombinant Human 57 6R BH4 56 Proxinium TM 56 GSK# [002] 56 Gleevec resistant 56 inflammatory autoimmune diseases 56 PD LID 56 PEP# [003] 56 Vilazodone 56 amrubicin 56 PEGPH# 56 Irinotecan 56 Genz # 56 Triolex 56 Apoptone 56 pharmacokinetics PK 56 factor VIIa 56 Cloretazine R VNP#M 56 immune modulating 56 Roflumilast 56 MEK inhibitors 56 administered subcutaneously 56 Tumor Necrosis Factor 56 Lu AA# 56 ZFP Therapeutics 56 antiproliferative 56 nosocomial pneumonia 56 Preclinical studies 56 TOLAMBA 56 faropenem 56 nasal powder 56 topical non steroidal 56 inflammation autoimmune diseases 56 Noxafil